Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (the “Company”), a development‐stage biotechnology company developing new medicines ...

Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of ...

Praxis Precision Medicines' vormatrigine shows promise in epilepsy with 56.3% seizure reduction. Click here to find out why I ...

A new study meticulously sampled different lung regions in people with cystic fibrosis to understand why infections persist ...

Equillium, Inc. (Nasdaq: EQ), a biotechnology innovator developing novel therapies to treat severe autoimmune and ...

Manhattan’s very own synth wizard Tom Oberheim will be honored with the Bob Hapgood Award by the Kansas Music Hall of Fame.

The adjuster was created by the former Progressive Conservative government of Blaine Higgs in 2023 to allow oil companies to ...

The regulatory model designed to foster new competitors, more consumer choice and lower prices has enjoyed modest success, at best ...

Neumora is currently conducting preclinical DIO studies to characterize the potential of NMRA-215 in obesity and expects to report data in 2025. Additionally, Neumora expects to progress NMRA-215 into ...

Halifax Regional Municipality Mayor Andy Fillmore, Nova Scotia Premier Tim Houston and Municipal Affairs Minister John Lohr ...

Harry Springer, 21, has been sentenced to more than nine years in prison after making bomb threats against Compass High ...

Clinical pipeline advanced, with key Phase 3 trials in major depressive disorder and new studies entering clinic. These 10 stocks could mint the next wave of millionaires › Neumora Therapeutics ...